Glycosaminoglycans are not indispensable for the anti-herpes simplex virus type 2 activity of lactoferrin

Biochimie

Volumn 91, Issue 1, 2009, Pages 155-159

  Marchetti, M ^a   Ammendolia, M G ^a   Superti, F ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Antivirals; Glycosaminoglycans; Herpes simplex virus type 2; Lactoferrin

Indexed keywords

GLYCOSAMINOGLYCAN; LACTOFERRIN;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG INHIBITION; DRUG MECHANISM; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; PROTEIN INTERACTION; VIRUS MORPHOLOGY; VIRUS STRAIN;

ANIMALS; CATTLE; CELL LINE; CERCOPITHECUS AETHIOPS; GLYCOSAMINOGLYCANS; HERPESVIRUS 2, HUMAN; HUMANS; LACTOFERRIN; MICE;

BOVINAE; HERPES; HERPESVIRIDAE; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2;

EID: 58149134215     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2008.04.015     Document Type: Article

References (34)

1. Hasegawa K., Motsuchi W., Tanaka S., and Dosako S. Inhibition with lactoferrin of in vitro infection with human herpes virus. Jpn. J. Med. Sci. Biol. 47 (1994) 73-85
2. Marchetti M., Longhi C., Conte M.P., Pisani S., Valenti P., and Seganti L. Lactoferrin inhibits herpes simplex virus type1 adsorption to Vero cells. Antiviral Res. 29 (1996) 221-231
3. Marchetti M., Pisani S., Antonini G., Valenti P., Seganti L., and Orsi N. Metal complexes of bovine lactoferrin inhibit in vitro replication of herpes simplex virus type 1 and 2. BioMetals 11 (1998) 89-94
4. Marchetti M., Trybala E., Superti F., Johansson M., and Bergström T. Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans. Virology 318 (2004) 405-413
5. Andersen J.H., Jenssen H., Sandvik K., and Gutteberg T.J. Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface. J. Med. Virol. 74 (2004) 262-271
6. Jenssen H. Anti herpes simplex virus activity of lactoferrin/lactoferricin - an example of antiviral activity of antimicrobial protein/peptide. Cell. Mol. Life Sci. 62 (2005) 3002-3013
7. Herold B.C., WuDunn D., Soltys N., and Spear P.G. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 65 (1991) 1090-1098
8. Mårdberg K., Trybala E., Tufaro F., and Bergström T. Herpes simplex virus type 1 glycoprotein C is necessary for efficient infection of chondroitin sulfate-expressing gro2C cells. J. Gen. Virol. 83 (2002) 291-300
9. Shukla D., Liu J., Blaiklock P., Shworak N.W., Bai X., Esko J.D., Cohen G.H., Eisenberg R.J., Rosenberg R.D., and Spear P.G. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99 (1999) 13-22
10. Montgomery R.I., Warner M.S., Lum B.J., and Spear P.G. Hepes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87 (1996) 427-436
11. Geraghty R.J., Krummenacher C., Cohen G.H., Eisenberg R.J., and Spear P.G. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 280 (1998) 1618-1620
12. Herold B.C., WuDunn D., Visalli R.J., Sumarski N., Brandt C., and Spear P.G. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulfate and glycoprotein B. J. Gen. Virol. 75 (1994) 1211-1222
13. Herold B.C., Gerber S.I., Belval B.J., Siston A.M., and Shulman N. Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry. J. Virol. 70 (1996) 3461-3469
14. Gerber S.I., Belval B.J., and Herold B.C. Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism. Virology 214 (1995) 29-39
15. Friedman H.M., Cohen G.H., Eisenberg R.J., Seidel C., and Cines D.B. Glycoprotein C of herpes simplex virus type 1 acts as a receptor for C3b component of complement on infected cells. Nature 309 (1984) 633-635
16. Trybala E., Liljeqvist J.-A., Svennerholm B., and Bergström T. Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate. J. Virol. 74 (2000) 9106-9114
17. Hutton R.D., Ewert D.L., and French G.R. Differentiation of types 1 and 2 of herpes simplex virus by plaque inhibition with sulfated polyanions. Proc. Soc. Exp. Biol. Med. 142 (1973) 27-29
18. Langeland N., Holmsen H., Lillehaug J.R., and Haarr L. Evidence that neomycin inhibits binding of herpes simplex virus type 1 to the cellular receptor. J. Virol. 61 (1987) 3388-3393
19. Langeland N., Moore L.J., Holmsen H., and Haarr L. Interaction of polylysine with the cellular receptor for herpes simplex virus type 1. J. Gen. Virol. 69 (1988) 1137-1145
20. McCormick C., Leduc Y., Martindale D., Mattison K., Esford L.E., and Dyer A.P. The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate. Nat. Genet. 19 (1998) 158-161
21. Gruenheid S., Gatzke L., Meadows H., and Tufaro F. Herpes simplex virus infection and propagation in a mouse L cell mutant lacking heparan sulfate proteoglycans. J. Virol. 67 (1993) 93-100
22. Banfield B.W., Leduc Y., Esford L., Schubert K., and Tufaro F. Sequential isolation of proteoglycan synthesis mutants by using herpes simplex virus as a selective agent: evidence for a proteoglycan-independent virus entry pathway. J. Virol. 69 (1995) 3290-3298
23. Uyama T., Ishida M., Izumikawa T., Trybala E., Tufaro F., Bergström T., Sugahara K., and Kitagawa H. Chondroitin 4-O-sulfotransferase-1 regulates E disaccharide expression of chondroitin sulfate required for herpes simplex virus infectivity. J. Biol. Chem. 281 (2006) 38668-38674
24. Duff R., and Rapp F. Oncogenic transformation of hamster cells after exposure to herpes simplex virus type 2. Nat. New Biol. 233 (1971) 48-50
25. Holland T.C., Marlin S.D., Levine M., and Glorioso J. Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies. J. Virol. 45 (1983) 672-682
26. Holland T.C., Homma F.L., Marlin S.D., Levine M., and Glorioso J. Herpes simplex virus type 1 glycoprotein C-negative mutants exhibit multiple phenotypes, including secretion of truncated glycoproteins. J. Virol. 52 (1984) 566-574
27. Pietrantoni A., Ammendolia M.G., Tinari A., Siciliano R., Valenti P., and Superti F. Bovine lactoferrin peptidic fragments involved in inhibition of Echovirus 6 in vitro infection. Antiviral Res. 69 (2006) 98-106
28. Mann D.M., Romm E., and Migliorini M. Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin. J. Biol. Chem. 269 (1994) 23661-23667
29. Moore S.A., Anderson B.F., Groom C.R., Haridas M., and Baker E.N. Three-dimensional structure of diferric bovine lactoferrin at 2.8 Å resolution. J. Mol. Biol. 274 (1997) 222-236
30. Shimazaki K., Tazume T., Uji K., Tanaka M., Kumura H., Mikawa K., and Shimo-Oka T. Properties of a heparin-binding peptide derived from bovine lactoferrin. J. Dairy Sci. 81 (1998) 2841-2849
31. Pierce A., Colavizza D., Benaissa M., Maes P., Tartar A., Montreuil J., and Spik G. Molecular cloning and sequence analysis of bovine lactotransferrin. Eur. J. Biochem. 196 (1991) 177-184
32. Rey M.W., Woloshuk S.L., de Boer H.A., and Pieper F.R. Complete nucleotide sequence of human mammary gland lactoferrin. Nucleic Acids Res. 18 (1990) 5288
33. van Berkel P.H.C., Geerts M.E.J., van Veen H.A., Kooiman P.M., Pieper F., de Boer H.A., and Nuijens J.H. Glycosylated and unglycosylated human lactoferrins can both bind iron and have identical affinities towards human lysozyme and bacterial lipopolysaccharide, but differ in their susceptibility towards tryptic proteolysis. Biochem. J. 312 (1995) 107-114
34. Wei Z., Nishimura T., and Yoshida Y. Characterization of glycans in a lactoferrin isoform, lactoferrin-a. J. Dairy Sci. 84 (2001) 2584-2590